| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
519 |
392 |
$43K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
451 |
439 |
$41K |
| 59400 |
Routine obstetric care including antepartum care, vaginal delivery, and postpartum care |
124 |
123 |
$40K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
520 |
506 |
$32K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,835 |
4,818 |
$25K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,458 |
5,447 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,068 |
3,057 |
$19K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
694 |
691 |
$12K |
| 92551 |
|
10,996 |
10,955 |
$12K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,188 |
2,174 |
$8K |
| 96150 |
|
753 |
748 |
$7K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
190 |
180 |
$7K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
274 |
176 |
$7K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
135 |
134 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,053 |
1,044 |
$5K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
170 |
170 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
166 |
104 |
$4K |
| V2020 |
Frames, purchases |
188 |
188 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,082 |
1,073 |
$4K |
| 85018 |
|
14,716 |
14,651 |
$4K |
| 90651 |
|
1,843 |
1,830 |
$2K |
| 90670 |
|
2,210 |
2,192 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,895 |
6,680 |
$2K |
| 90633 |
|
1,495 |
1,482 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
972 |
966 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
49 |
49 |
$2K |
| 90698 |
|
1,563 |
1,549 |
$2K |
| 90716 |
|
1,484 |
1,477 |
$2K |
| 90686 |
|
3,472 |
3,461 |
$2K |
| 90707 |
|
1,370 |
1,362 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
15 |
14 |
$2K |
| 90715 |
|
930 |
921 |
$1K |
| 90734 |
|
1,300 |
1,288 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,125 |
1,103 |
$1K |
| 90680 |
|
1,306 |
1,295 |
$1K |
| 92015 |
Determination of refractive state |
253 |
253 |
$1K |
| 90620 |
|
836 |
828 |
$1K |
| 90744 |
|
1,038 |
1,028 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,511 |
25,539 |
$1K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
118 |
94 |
$995.19 |
| 90696 |
|
761 |
756 |
$963.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
15 |
$925.73 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
13 |
$667.03 |
| 90700 |
|
694 |
690 |
$549.00 |
| 83655 |
|
1,168 |
1,153 |
$526.19 |
| 90648 |
|
495 |
493 |
$495.00 |
| 86580 |
|
711 |
701 |
$436.23 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
3,464 |
3,427 |
$417.30 |
| 81025 |
|
552 |
529 |
$393.37 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,019 |
1,961 |
$323.95 |
| 99000 |
|
7,019 |
6,622 |
$243.17 |
| 81000 |
|
7,460 |
7,356 |
$194.50 |
| 86703 |
|
689 |
687 |
$191.24 |
| 80053 |
Comprehensive metabolic panel |
2,903 |
2,857 |
$191.04 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
971 |
934 |
$153.79 |
| 86592 |
|
1,068 |
1,059 |
$104.17 |
| 96156 |
|
334 |
332 |
$100.00 |
| 90714 |
|
229 |
226 |
$90.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
136 |
133 |
$65.78 |
| 80061 |
Lipid panel |
3,255 |
3,219 |
$55.81 |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,104 |
3,069 |
$53.71 |
| 84702 |
|
30 |
26 |
$40.27 |
| 82947 |
|
534 |
531 |
$36.28 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
227 |
223 |
$29.68 |
| G9920 |
Screening performed and negative |
333 |
333 |
$29.00 |
| 90672 |
|
684 |
683 |
$27.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,462 |
2,434 |
$24.67 |
| 99173 |
|
11,106 |
11,044 |
$24.29 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
883 |
880 |
$23.44 |
| A4649 |
Surgical supply; miscellaneous |
64 |
54 |
$20.55 |
| 81001 |
|
130 |
126 |
$5.33 |
| 92556 |
|
457 |
455 |
$0.00 |
| 3079F |
|
39 |
37 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,373 |
1,204 |
$0.00 |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
1,345 |
875 |
$0.00 |
| 87110 |
|
314 |
311 |
$0.00 |
| 87088 |
|
64 |
61 |
$0.00 |
| 82951 |
|
108 |
102 |
$0.00 |
| 96127 |
|
178 |
177 |
$0.00 |
| G0306 |
Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count |
54 |
53 |
$0.00 |
| 90657 |
|
409 |
397 |
$0.00 |
| 99384 |
|
26 |
26 |
$0.00 |
| 3074F |
|
73 |
66 |
$0.00 |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
474 |
474 |
$0.00 |
| 87590 |
|
149 |
148 |
$0.00 |
| 59430 |
|
12 |
12 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
351 |
350 |
$0.00 |
| 87070 |
|
102 |
102 |
$0.00 |
| 82670 |
|
12 |
12 |
$0.00 |
| 99385 |
|
67 |
67 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
59 |
59 |
$0.00 |
| 99381 |
|
77 |
77 |
$0.00 |
| 99383 |
|
81 |
81 |
$0.00 |
| 3044F |
|
12 |
12 |
$0.00 |
| 3080F |
|
12 |
12 |
$0.00 |
| 80055 |
|
13 |
13 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
115 |
115 |
$0.00 |
| 94664 |
|
51 |
48 |
$0.00 |
| 81002 |
|
528 |
513 |
$0.00 |
| 59425 |
|
1,820 |
1,108 |
$0.00 |
| 3077F |
|
112 |
95 |
$0.00 |
| 99199 |
Unlisted special service, procedure or report |
44 |
39 |
$0.00 |
| H0003 |
Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs |
136 |
133 |
$0.00 |
| 92081 |
|
990 |
986 |
$0.00 |
| 84439 |
|
68 |
67 |
$0.00 |
| 99188 |
|
1,507 |
1,501 |
$0.00 |
| 90713 |
|
82 |
79 |
$0.00 |
| 3078F |
|
156 |
143 |
$0.00 |
| 90791 |
Psychiatric diagnostic evaluation |
15 |
15 |
$0.00 |
| 99382 |
|
40 |
40 |
$0.00 |
| 84481 |
|
61 |
60 |
$0.00 |
| 80076 |
|
58 |
57 |
$0.00 |
| 80306 |
|
27 |
27 |
$0.00 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
12 |
12 |
$0.00 |
| 92552 |
|
55 |
53 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
14 |
14 |
$0.00 |
| 86677 |
|
12 |
12 |
$0.00 |